Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not revealed, but it will bolster Novartis's cancer immunotherapy portfolio.
ThinkstockSpeculation has run hot that Swiss drugmaker Novartis A.G. (NYSE: NVS) would announced further restructuring at its investor day in London. Instead, on Friday the company announced a $5 billion share buyback…
ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company ViroPharma (NASDAQ: VPHM) in…
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top companies…
ThinkstockWith yields on 10-year Treasury bonds up nearly 1.5% since early May and briefly touching 3.0% last week, the impact of higher rates on stocks continues to be top of mind for…
ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a stalking horse bid, that’s what many observers expect to be the result.…
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their coverage universe to find the best…
ThinkstockAfter a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However they are…
courtesy of AppleIn its third annual ranking of the world’s most innovative companies, analysts at Booz & Co. created two lists: one based on dollars spent and the other based on asking…
A new consumer agency fines Capital One (NYSE: COF) $210 million for aggressive marketing activity.(Reuters) New IMF policies will examine whether individual national economies might hurt global growth. (Reuters) IBM (NYSE: IBM) raises…
The CEO of Chrysler said he took no pay in 2011 and that, based on financial results, the company is now worth $7.5 billion. (Reuters) The Treasury will sell $6 billion of…
The public and the press usually measure unemployment one month at a time as data from ADP and the federal government are issued. The jobs market can also be tracked in another…
Layoffs have surged recently. There is no telling why they happened all at about the same time. Drug giant Novartis (NYSE: NVS) said it will cut nearly 2,000 jobs. Food Lion will shut…
TPG may invest $1 billion in troubled Olympus. (Reuters) President Obama to ask for a $1.2 trillion increase in the national debt ceiling. (Reuters) China’s foreign currency reserves drop to $3.18 trillion,…
Drug maker Novartis AG (NYSE: NVS) has issued a recall notice for several of its popular over-the-counter medicines: Novartis Consumer Health (NCH) is voluntarily recalling all lots of select bottle sizes of…
Paul Ausick 
